Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
J Biomol Struct Dyn ; : 1-12, 2023 Oct 09.
Artículo en Inglés | MEDLINE | ID: mdl-37811765

RESUMEN

Radiation resistance is one of the major problems in the treatment of small cell lung cancer (SCLC). Most of these patients are given radiation as first-line treatment and it was observed that the initial response in these patients is very good. However, they show relapse in a few months which is also associated with resistance to treatment. Thus, targeting the mechanism by which these cells develop resistance could be an important strategy to improve the survival chances of these patients. From the RNA-Seq data analysis, it was identified that CHEK1 gene was overexpressed. Chk1 protein which is encoded by the CHEK1 gene is an important protein that is involved in radiation resistance in SCLC. It is known to favour the cells to deal with replicative stress. CHEK1 is the major cause for developing radiation resistance in SCLC. Thus, natural compounds that could also serve as potential inhibitors for Chk1 were explored. Accordingly; the compounds were screened based on ADME, docking and MM-GBSA scores. MD simulations were performed for the selected protein-ligand complexes and the results were compared to the co-crystallised ligand, 3-(indol-2-yl)indazole. The results showed that compound INC000033832986 could be a natural alternative to the commercial ligand for the prevention of SCLC.Communicated by Ramaswamy H. Sarma.

2.
Comput Biol Med ; 134: 104462, 2021 07.
Artículo en Inglés | MEDLINE | ID: mdl-34148008

RESUMEN

BACKGROUND: Chlorogenic acid is amongst the well-known polyphenolic compounds being used in human food and beverages. Its presence has been reported in tea leaves, roasted green beans, coffee, cocoa, berry fruits, apples, citrus fruits, and pears. OBJECTIVE: The present study aims to elucidate the effectiveness of chlorogenic acid on in silico and in vitro inhibition of glucose metabolising enzymes (α-amylase and α-glucosidase) and on blood-based markers associated with diabetic complications in vivo. METHODS: Docking and molecular dynamics studies were performed using GLIDE (Schrodinger, LLC, NY, 2019-2) and Maestro-Desmond Interoperability Tools, version 4.1 (Schrödinger, NY, 2015), respectively. α-Amylase and α-glucosidase inhibitory activities of chlorogenic acid were measured in vitro. Diabetes was induced in adult Wistar rats by injecting streptozotocin (50 mg/kg). Biochemical assays were performed using standard kits. RESULT: The in silico studies for α-amylase and α-glucosidase with chlorogenic acid suggested that the ligand was stable and strongly bound with the above-mentioned proteins. During in vitro studies, chlorogenic acid inhibited both the enzymes in a dose-dependent manner (5-30 µg/mL). In addition, chlorogenic acid treatment for 28 days significantly suppressed the increase in blood glucose, total cholesterol, triglyceride, glutamic oxaloacetic transaminase, glutamic pyruvic transaminase, γ-glutamyl transferase, alkaline phosphatase, total bilirubin, creatinine, urea, uric acid, and feed intake levels in diabetic rats. Chlorogenic acid also caused significant improvement in body weight, serum HDL-cholesterol, total protein, and albumin levels leading to betterment in atherogenic indices related to diabetes-associated cardiovascular risks. CONCLUSION: The findings indicated that chlorogenic acid inhibited α-amylase and α-glucosidase and significantly decreased diabetes associated hyperglycemia, hyperlipidemia, and hepatorenal damage, making it a possible functional food ingredient and drug candidate for the management of diabetes and related complications.


Asunto(s)
Diabetes Mellitus Experimental , Hipoglucemiantes , Animales , Ácido Clorogénico/farmacología , Diabetes Mellitus Experimental/tratamiento farmacológico , Inhibidores de Glicósido Hidrolasas , Hipoglucemiantes/farmacología , Simulación del Acoplamiento Molecular , Simulación de Dinámica Molecular , Extractos Vegetales , Ratas , Ratas Wistar , Estreptozocina/toxicidad
3.
Mater Sci Eng C Mater Biol Appl ; 95: 57-71, 2019 Feb 01.
Artículo en Inglés | MEDLINE | ID: mdl-30573271

RESUMEN

Heat shock proteins (HSPs) emerged as a therapeutic target and it was observed that inhibition of HSP70-1 plays a pivotal role in the management of psoriasis. In-silico investigation involving techniques like molecular docking and molecular dynamics (MD) simulation analysis was performed against HSP70-1. Further, anti-psoriatic activity of bioactive immunomodulatory compounds present in ethanolic extract of Woodfordia fruticosa flowers (Wffe) using combination of bioinformatics together with ethnopharmacological approach has been explored in this study. Myricetin (-8.024), Quercetin (-7.368) and Ellagic acid (-7.311) were the top three compounds with minimum energy levels as well as high therapeutic value/ADMET as compared to currently available marketed anti-psoriatic drug Tretinoin (-7.195). ADMET prediction was used to screen ligands for drug-likeness and efficacy. Further, biogenically Woodfordia fruticosa gold nanoparticles (WfAuNPs) were synthesized and characterized by UV-Visible Spectroscopy (UV-vis), Dynamic Light Scattering (DLS), Zeta Potential, X-Ray Diffraction (XRD) and High Resolution Transmission Electron Microscopy (HRTEM) techniques. Synthesized WfAuNPs observed in the size range of 10-20 nm and were used to develop WfAuNPs-Carbopol®934 ointment gel. Subsequently, the therapeutic efficacy of WfAuNPs-Carbopol® 934 was checked against 5% Imiquimod-induced psoriasis like skin inflammation. WfAuNPs-Carbopol® 934 was found to be exerting better therapeutic effect in reducing the mean DAI score (0.63 ±â€¯0.08), serum cytokines (TNF-α, IL-22 and IL-23) levels along with reduced epidermal thickness, parakeratosis and marked decrease in the hyperproliferation of keratinocytes. Results of the study revealed that the WfAuNPs-Carbopol® 934 could be an effective alternative treatment for psoriasis in near future.


Asunto(s)
Proteínas de Choque Térmico/metabolismo , Imiquimod/toxicidad , Psoriasis/inducido químicamente , Psoriasis/tratamiento farmacológico , Enfermedades de la Piel/tratamiento farmacológico , Woodfordia/química , Animales , Modelos Animales de Enfermedad , Oro/química , Humanos , Nanopartículas del Metal/química , Ratones , Simulación del Acoplamiento Molecular , Psoriasis/metabolismo , Enfermedades de la Piel/inducido químicamente , Enfermedades de la Piel/metabolismo
4.
J Biomol Struct Dyn ; 37(9): 2355-2369, 2019 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-30047324

RESUMEN

Natural products acquire massive structural and chemical diversity, which cannot be coordinated by any synthetic libraries for small molecules and they are continuing to inspire novel discoveries in health sciences. We have performed the computational calculations for geometry optimization and prediction of electronic and structural properties of some plant phenolic compounds through Gaussian 09 program. Energies of molecular orbitals were computed, to mimic out the stabilities arising from charge delocalization and intramolecular interactions. This process indicated the eventual charge transfer within the molecules. The molecular docking and ADMET properties of these compounds with a novel anticancer (HER2) and anti-inflammatory (COX-2) targets revealed that two molecules were capable of inhibiting both the targets, and could be used as multi target inhibitors. Furthermore, molecular dynamics simulation studies were performed to elucidate the binding mechanism and the comparison of inhibitor's binding mode with diverse biological activities as anticancer and anti-inflammatory agents. A high-quality association was reported among quantum chemical, ADMET, docking, dynamics and MMGBSA results. Communicated By Ramaswamy H. Sarma.


Asunto(s)
Antiinflamatorios/química , Antineoplásicos/química , Productos Biológicos/química , Hidroxibenzoatos/química , Antiinflamatorios/metabolismo , Antiinflamatorios/farmacología , Antineoplásicos/metabolismo , Antineoplásicos/farmacología , Productos Biológicos/metabolismo , Productos Biológicos/farmacología , Evaluación Preclínica de Medicamentos/métodos , Humanos , Hidroxibenzoatos/metabolismo , Hidroxibenzoatos/farmacología , Inflamación/metabolismo , Inflamación/prevención & control , Simulación del Acoplamiento Molecular , Simulación de Dinámica Molecular , Neoplasias/metabolismo , Neoplasias/prevención & control , Plantas/química , Unión Proteica
5.
Curr Top Med Chem ; 18(20): 1745-1754, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-30360720

RESUMEN

The conventional way of characterizing a disease consists of correlating clinical symptoms with pathological findings. Although this approach for many years has assisted clinicians in establishing syndromic patterns for pathophenotypes, it has major limitations as it does not consider preclinical disease states and is unable to individualize medicine. Moreover, the complexity of disease biology is the major challenge in the development of effective and safe medicines. Therefore, the process of drug development must consider biological responses in both pathological and physiological conditions. Consequently, a quantitative and holistic systems biology approach could aid in understanding complex biological systems by providing an exceptional platform to integrate diverse data types with molecular as well as pathway information, leading to development of predictive models for complex diseases. Furthermore, an increase in knowledgebase of proteins, genes, metabolites from high-throughput experimental data accelerates hypothesis generation and testing in disease models. The systems biology approach also assists in predicting drug effects, repurposing of existing drugs, identifying new targets, facilitating development of personalized medicine and improving decision making and success rate of new drugs in clinical trials.


Asunto(s)
Diseño de Fármacos , Desarrollo de Medicamentos/métodos , Biología de Sistemas/métodos , Combinación de Medicamentos , Sistemas de Liberación de Medicamentos , Reposicionamiento de Medicamentos , Humanos , Fenotipo
6.
Interdiscip Sci ; 10(2): 271-281, 2018 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-27696208

RESUMEN

Psoriasis is a chronic immune-mediated inflammatory skin disorder. Heat shock proteins (HSPs) have been witnessed as a potential drug target for inhibition of psoriatic cell differentiation. The expression level of HSP is increased when the cells get exposed to elevated temperature, oxidative stress and nutritional deficiencies and thus plays major role in psoriatic progression pathway. Immunoreactivity intensity distribution index scores for HSP70 expression is significantly higher in psoriatic patients compared to normal. In the present work, the 3D structure of human Hsp70 has been taken. Inhibition of HSP70 can control the severity of psoriasis up to many folds; thus, virtual screening was performed against lead-like, drug-like and some natural product of ZINC database. The screened ligands were further introduced to ADMET prediction and simulations to see the drug proficiency and likeness property. The molecular dynamic of system was found stable during simulation trajectory and not much of significant changes occurred in the conformation of the protein-ligand complex. Thus, present study in all probability might prove useful for future design of new derivatives with higher potency and specificity.


Asunto(s)
Simulación por Computador , Diseño de Fármacos , Proteínas HSP70 de Choque Térmico/antagonistas & inhibidores , Psoriasis/tratamiento farmacológico , Evaluación Preclínica de Medicamentos , Humanos , Ligandos , Simulación del Acoplamiento Molecular , Estabilidad Proteica , Relación Estructura-Actividad , Termodinámica
7.
Asian Pac J Cancer Prev ; 16(9): 3817-25, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-25987043

RESUMEN

BACKGROUND: The human protein methyl-transferase DOT1L catalyzes the methylation of histone H3 on lysine 79 (H3K79) at homeobox genes and is also involved in a number of significant processes ranging from gene expression to DNA-damage response and cell cycle progression. Inhibition of DOT1L activity by shRNA or small-molecule inhibitors has been established to prevent proliferation of various MLL-rearranged leukemia cells in vitro, establishing DOT1L an attractive therapeutic target for mixed lineage leukemia (MLL). Most of the drugs currently in use for the MLL treatment are reported to have low efficacy, hence this study focused on various natural compounds which exhibit minimal toxic effects and high efficacy for the target receptor. MATERIALS AND METHODS: Structures of human protein methyl-transferase DOT1L and natural compound databases were downloaded from various sources. Virtual screening, molecular docking, dynamics simulation and drug likeness studies were performed for those natural compounds to evaluate and analyze their anti-cancer activity. RESULTS: The top five screened compounds possessing good binding affinity were identified as potential high affinity inhibitors against DOT1L's active site. The top ranking molecule amongst the screened ligands had a Glide g-score of -10.940 kcal/mol and Glide e-model score of -86.011 with 5 hydrogen bonds and 12 hydrophobic contacts. This ligand's behaviour also showed consistency during the simulation of protein-ligand complex for 20000 ps, which is indicative of its stability in the receptor pocket. CONCLUSIONS: The ligand obtained out of this screening study can be considered as a potential inhibitor for DOT1L and further can be treated as a lead for the drug designing pipeline.


Asunto(s)
Evaluación Preclínica de Medicamentos , Leucemia/tratamiento farmacológico , Metiltransferasas/antagonistas & inhibidores , Simulación del Acoplamiento Molecular , Simulación de Dinámica Molecular , ARN Interferente Pequeño/genética , Bibliotecas de Moléculas Pequeñas/farmacología , Dominio Catalítico , Diseño de Fármacos , N-Metiltransferasa de Histona-Lisina , Humanos , Leucemia/metabolismo , Ligandos , Metiltransferasas/genética , Metiltransferasas/metabolismo
8.
Funct Integr Genomics ; 8(3): 287-300, 2008 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-18305970

RESUMEN

The response of a grass halophyte Spartina alterniflora at early stages of salt stress was investigated through generation and systematic analysis of expressed sequence tags (ESTs) from both leaf and root tissues. Random EST sequencing produced 1,227 quality ESTs, which were clustered into 127 contigs, and 368 were singletons. Of the 495 unigenes, 27% represented genes for stress response. Comparison of the 368 singletons against the Oryza sativa gene index showed that >85% of these genes had similarity with the rice unigenes. Moreover, the phylogenetic analysis of an EST similar to myo-inositol 1-phosphate synthase of Spartina and some selected grasses and halophytes showed closeness of Spartina with maize and rice. Transcript abundance analysis involving eight known genes of various metabolic pathways and nine transcription factor genes showed temporal and tissue-dependent variation in expression under salinity. Reverse northern analysis of a few selected unknown and ribosomal genes exhibited much higher abundance of transcripts in response to salt stress. The results provide evidence that, in addition to several unknown genes discovered in this study, genes involved in ion transport, osmolyte production, and house-keeping functions may play an important role in the primary responses to salt stress in this grass halophyte.


Asunto(s)
Etiquetas de Secuencia Expresada , Regulación de la Expresión Génica de las Plantas/efectos de los fármacos , Genes de Plantas , Poaceae/genética , Cloruro de Sodio/farmacología , Análisis por Conglomerados , ADN Complementario/genética , ADN de Plantas , Escherichia coli/genética , Biblioteca de Genes , Filogenia , Hojas de la Planta/genética , Raíces de Plantas/genética , Plásmidos , Poaceae/efectos de los fármacos , Poaceae/metabolismo , ARN Mensajero/metabolismo , ARN de Planta/genética , ARN de Planta/aislamiento & purificación , Análisis de Secuencia de ADN , Factores de Transcripción/genética , Factores de Transcripción/metabolismo , Transcripción Genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA